Tofacitinib (CP-690,550), an oral janus kinase inhibitor, as monotherapy in patients with active rheumatoid arthritis: A comparison between japanese and global populations over 12 weeks of dosing in phase 2b studies

Category Primary study
JournalArthritis and Rheumatism
Year 2011
This article has no abstract
Epistemonikos ID: 77282c7a8b52a16b8ea47bf32c86dce6c038ddf3
First added on: Feb 05, 2025